Abstract
The adverse effects of pegylated liposomal doxorubicin are primarily cutaneous. The majority of these cutaneous side effects manifest as palmar-plantar erythrodysesthesia, whereas few reports of other cutaneous reactions exist in the literature. The authors report a case of an exuberant follicular eruption in a patient treated with pegylated liposomal doxorubicin. This case also highlights the potential mechanism underlying this unusual histological and clinical reaction.
Original language | English (US) |
---|---|
Pages (from-to) | 590-591 |
Number of pages | 2 |
Journal | American Journal of Dermatopathology |
Volume | 36 |
Issue number | 7 |
DOIs | |
State | Published - Jul 2014 |
Externally published | Yes |
Keywords
- follicular rash
- pegylated liposomal doxorubicin
ASJC Scopus subject areas
- Pathology and Forensic Medicine
- Dermatology